Back to results
US 8,772,455 B2Granted
Markers for identifying tumor cells, methods and kit thereof
AssigneeOncostem Diagnostics (Mauritius) Pvt. Ltd.
InventorManjiri Bakre
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a combination of biological markers for identification of prognosis of cancer. The present disclosure further relates to a method of identifying the said markers, a method of predicting prognosis and a method of planning personalized treatment for cancer. The present disclosure further relates to a kit/test comprising the antibodies against/other methods of detecting said markers for the said prediction.
Claims3
A combination of
- biological markers consisting of CD44, ABCC4, P-cadherin and β-catenine
- for prognosis of breast cancer or recurrence of breast cancer, based on the estrogen receptor and progesterone receptor status.
Dependencies are inferred from the claim text.